Biomechanical properties of an implant designed to stabilize the coxofemoral joint following luxation show dissimilarity to the native ligament of the head of the femur in cattle.

OBJECTIVE: To improve upon the toggle-pin implant construction and develop a repeatable surgical technique to achieve coxofemoral stabilization in mature cattle. ANIMALS: 9 adult bovine cadaveric coxofemoral joints, 8 bovine femurs, 2 beef calf cadavers. PROCEDURES: Ultimate tensile strength and elongation at failure were measured for the native ligament of the head of the femur (LOHOF) harvested up to 48 hours after death, and the prosthetic prototype utilizing stainless-steel cable and prosthetic prototype utilizing nylon leader line were compared. Bovine femurs were utilized to locate the ideal and repeatable trajectory of the prosthetic ligament to exit at the origin of the LOHOF. Using fluoroscopy, thawed calf cadavers with radiopaque markers placed at sites of origin and insertion of the LOHOF were positioned to assess limb angle to maximize joint isometry resulting in the ideal placement of the LOHOF prosthesis. The study was performed between February 1, 2020, and December 1, 2021. RESULTS: The stainless-steel prototype had a significantly higher ultimate tensile strength and significantly decreased elongation at failure when compared to the LOHOF, while the nylon-based prototype had significantly decreased tensile strength and elongation at failure compared to the LOHOF. Therefore, neither prototypes were biomechanically similar to LOHOF. CLINICAL RELEVANCE: The stainless-steel prosthetic prototype shows promise to provide superior stabilization to the luxated coxofemoral joint.

The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics.

The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at harvest in cross bred beef cattle. Multisourced, crossbred steer calves (n = 168) consisting of mainly British and British-Continental breeds were purchased from an auction market in central Missouri. Calves were processed prior to transportation and again upon feedlot arrival. Animals were randomized to 3 separate treatments: pretransport meloxicam (PMEL), arrival meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Dosing at 1 mg/kg on weighted averaged administered per os. Animals were weighed and blood was collected pre- and post-transport. Haptoglobin (Hp)-matrix metaloproteinase (MMP)-9 complex, cortisol, and substance P were quantified. Weights were taken again at 42 d and at harvest. Clinical signs of BRD were monitored using indicators of depression, appetite, respiration, and temperature that qualified the animals for treatment. Harvest parameters were collected using a standardized United States Department of Agriculture grading system for quality grade and yield grade. Meloxicam did not have a significant effect on BRD morbidity over the course of the study and there was no significant effect on performance characteristics at 42 d (P > 0.10). Of the calves that did succumb to BRD, no significant differences were found in severity of disease (P > 0.10). Concentrations of substance P and Hp- MMP-9, were increased on arrival (P ≤ 0.05) however no significant treatment effect or interaction were found between AMEL, PMEL, CONT, or across different levels of biomarkers (P > 0.10). Meloxicam use prior to or on arrival does not mitigate disease or improve performance during the feeding period.